When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KDMN - Kadmon's KD025 a Breakthrough Therapy for cGVHD; shares up 7% premarket
Kadmon Holdings Inc.
Kadmon Holdings (NYSE:KDMN) is up 7% premarket on light volume following its announcement that the FDA has designated KD025 a Breakthrough Therapy for the treatment of patients with chronic graft-versus-host disease (cGVHD) who have failed to respond to two or more prior lines of systemic therapy.
More news on: Kadmon Holdings, Healthcare stocks news, Stocks on the move,